Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study.
Conclusion: The IR of CV events in our Italian multicentre cohort was lower than that reported in other European and non-European cohorts. Low-dose ASA may have a role in the primary prophylaxis of CV events in RA patients.
PMID: 31192004 [PubMed]
Source: Cardiology Research and Practice - Category: Cardiology Authors: Iacono D, Fasano S, Pantano I, D'Abrosca V, Ruscitti P, Margiotta DPE, Navarini L, Maruotti N, Grembiale RD, Cantatore FP, Afeltra A, Giacomelli R, Valentini G Tags: Cardiol Res Pract Source Type: research
More News: Arthritis | Aspirin | Cardiology | Cardiovascular | Heart | Hydroxychloroquine | Hypertension | Italy Health | Rheumatoid Arthritis | Rheumatology | Study